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Background: Premenstrual syndrome (PMS) is a common problem among women and
is identified by reversal emotional, psychological, and physical signs during the luteal
phase. These signs, however, lower down in the follicular phase. The cause of PMS
isn’t very well-known up to nowControl group and many researchers have suggested
that mineral compounds and vitamins can inhibit these symptoms.
Objective: The objective of this study is to compare the serum level of some trace
elements and vitamin D between normal controls and patients with PMS.
Materials and Methods: 300 female students (19–21 yr old) from Falavarjan County
were randomly selected and asked to complete a standard questionnaire on PMS
during three menstruation cycles. The students were divided into two groups: healthy
persons (control) and PMS persons, and PMS was determined on the basis of
the answers to the questionnaire. Thereafter, the serum concentrations of zinc,
iron, calcium, magnesium, potassium, sodium, and Vitamin D3 were measured and
compared between the two groups.
Results: Our results showed that the PMS prevalence was about 41.5%. The level
of vitamin D decreased in both the control and PMS groups, with a significantly lower
range of vitamin D (p≤ 0.05) in the PMS group. Other factors had no significant change
between the two groups.
Conclusion: Vitamin D deficiency was probably one of the most important causes of
unpleasant symptoms of PMS between these students.
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1. Introduction
Premenstrual syndrome (PMS) is one of the
major health issue among women all over the world.
This syndrome is determined with more than 150
physical, behavioral, and psychological characters,
which begin during the luteal phase (7 to 14 days
before ovulation) and end in the menstrual phase.
Epidemiological studies have shown that about
80–90% of women have at least one of the PMS
sings; however, in about 2.5–3% of women, the
syndrome is so severe that it affects their personal
activities and social communications. This disorder
is called premenstrual dysphoric disorder (PMDD)
(1).
In spite of a host of studies, pathophysiological
causes of this syndrome remain unknown. PMS
symptoms occur in the menstrual cycle, so they can
be linked with hypothalamus-pituitary-gonad axis
deficiencies. Some researchers have established
that progesterone affects the secretion of some
neurotransmitters such as serotonin, GABA, opioid,
and catecholamine, and causes PMS signs to
appear (2).
While others believed that a deficiency in
adrenal hormone secretion and body electrolyte
imbalance are responsible for these symptoms.
Hormone-like and tranquilizing drugs and
traditional medicines are used to treat some
symptoms of PMS (1). Many women experimented
and found that vitamins and trace elements
(calcium, magnesium, iron) supplements can
reduce PMS symptoms, which has been confirmed
by some researches as well. Minerals and
vitamins play important roles as cofactor and
coenzyme in endocrine hormone synthesis
such as in hypothalamus-pituitary-ovary axis
(3), hence their deficiency might lead to similar
medical signs as PMS symptoms in the luteal
phase.
In this study, the percentage of PMS prevalence
in a number of students from the city of Falavarjan
was estimated, and the relationship of some serum
trace elements as well as vitamin D in suffered and
normal students was assessed.
2. Materials and Methods
This study was a cross-sectional study on 300
female students (aged 19–21-yr old, age of first
menstrual period 13–14-yr old) from Falavarjan
County between May and December 2016. They
were assessed based on the PMS questionnaire.
This questionnaire was based on an Iranian version
of the premenstrual symptoms screening tool
(PSST) (4), including 25 questions related to general
health and gynecological condition. Students were
asked to mark their signs and symptoms during
the last three menstruation cycles, and in this
way, having PMS was proven. Someone who
suffered any endocrine disorder or was taking
vitamin and mineral complements, corticosteroid
antidepressants, and oral contraceptive pill were
removed from the study.
Two wk after the menstrual period ended
during the luteal phase, vein blood samples
were taken following a fasting night. Serum
samples were prepared (2500 rpm, 10 min), and
then mineral parameters and vitamin D were
assessed.
The serum concentration of vitamin D was
measured by dihydroxy vitamin D diagnosis ELISA
kit (from Bio Rex Fars Inc.). Its normal range was
considered 30–70 ng/ml. The serum concentration
of calcium and magnesium were calculated by
Pars Azmoon kit using auto analyzer (Arsenazo
method) and photometric (Xylidl blue method),
respectively. The normal range of calcium and
magnesium were 8.2–10.6 mg/dl and 1.9–2.5 mg/dl,
respectively.
The serum concentration of iron and zinc
were evaluated by photometric method (Iron
assay kit, Abcam Company) and atomic absorption
flame method (Chemtech CTA 3000 England kit,
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wavelength: 213.9 nm and a slit width of 0.7 nm),
respectively. The normal range of iron was assumed
37–165 Ug/dl (for 12–25-yr old) and zinc serum
concentration less than 70 Ug/dl was presumed as
zinc deficiency.
The serum concentration of sodium and
potassium were assessed by the flame photometric
method. The normal range of sodium and potassium
concentrations was 135–145 mEq/L and 3.5–
5 mEq/L, respectively.
2.1. Ethical consideration
This study was conducted with the approval
of the Ethics Committee of Falavarjan (No:
IR.IAU.NAJAFABAD.REC.1397.017). All students
were informed about the project and had given
written consent before participating in the
study.
2.2. Statistical analysis
PMS percentage was calculated by descriptive
statistics. Normal distribution data verification of
serum factors was done by Kolmogorov-Smirnov
test. The results are presented as means ± SEM.
The significance of differences of all results was
analyzed by independent t-test. Significance was
considered as p ≤ 0.05.
3. Results
Two hundred and seventy eight cases out
of three hundred samples were eligible for
the analysis. Based on DSM-IV, the prevalence
distribution of PMS was 41.52% (Figure 1). According
to Figure 2, the highest percentage of psychotic
symptoms in PMS groups were irritability (53.91%),
depression (30.43%), and anxiety (21%), and the
maximum percentage of physical signs were
breast sensitivity (21.74%), abdominal distention
(19.13%), and general tiredness (18%). The serum
concentration of calcium, magnesium, zinc, iron,
sodium/potassium ratio, and vitamin D of PMS group
were less than the control group, but reveal no
significant difference except for vitamin D (p≤0.05).
It should be noted that vitamin D deficiency was
observed in both the PMS and control groups (198
out of 278 cases, 71.22%; Table I).
Figure 1. The prevalence of PMS in female students from
Falavarjan County (n = 278).
Table I. Serum levels of vitamin D and traces elements in the PMS and control groups
Factors Control group PMS group P-value∗
Calcium 9.79 ± 0.38 9.72 ± 0.43 0.265
Magnesium 2.10 ± 0.25 2.08 ± 0.21 0.672
Sodium/potassium 34.06 ± 2.31 33.67 ± 2.07 0.150
Zinc 84.41 ± 11.8 83.49 ± 11.58 0.521
Iron 85.76 ± 38.74 85.20 ± 25.08 0.857
Vitamin D 26.58 ± 6.74 22.44 ± 13.91 0.043∗
Values are means ± SEM; the results were analyzed using Independent student t-test
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Figure 2. Distribution of some of the physical and psychological symptoms among female with PMS.
4. Discussion
In our study, the PMS prevalence was 41.5%, so
our findings are almost in line with the previous
researches in Iran. The PMS prevalence among
the students of Shahid Beheshti of Tehran, the
Medical Sciences of Uromia (5, 6) and the Medical
Sciences of Mashhad (7) were 47.07%, 39.4%, and
48.1%, respectively. Based on the meta-analysis
and the systematic review of published papers
during 1996-2011, on ISI, PubMed, and Scopus
databases, the mean of the global PMS prevalence
was reported as 47.8% (8). According to our
results, irritability and breast sensitivity are the
most abundant psychotic and physical signs,
respectively. Even though our results differ from
some previous studies, our findings were consistent
with the most researches, as breast sensitivity,
abdominal distention, headache, weight gain,
fatigue, anxiety, depression, and anger were the
most abundant physical and psychotic symptoms
compared to the other signs (9, 10). It is certain that
the PMS sign percentage and intensity differences
can be related to the diversity of diagnostic
criteria, used methodology, climatic, cultural, and
geographic differences, and even volunteer’s age
and their lifestyle (1).
In regard to the probable relation of PMS signs
to serum levels of essential elements, serum levels
of calcium, magnesium, iron, zinc, potassium, and
sodium were also compared between the two
groups. The results showed a decrease in the level
of these elements in the PMS group compared with
the control group; of course, this reduction was
not significant. Mira and colleagues investigated
the plasma levels of magnesium and zinc and E
and B6 vitamins in PMS cases and didn’t observe
any relation between the PMS signs and these
serum parameters (11). Another study showed an
insignificant reduction of magnesium and calcium in
the PMS group (12). In contrast, some investigation
confirmed the significant reduction of zinc level and
total antioxidant capacity (13) in the PMS group
and copper, cadmium, calcium, and magnesium
reduction and ratio increase of magnesium to
calcium and potassium to sodium in erythrocyte of
PMS cases (14).
Although there are few contradictory documents
indicating no relationship between serum vitamins
and trace elements and PMS symptoms, many
types of research showed that the consumption of
this complement is effective in the management
of unpleasant PMS symptoms. For instance, iron,
magnesium, zinc, and potassium consumption by
1,968 healthy women during 10 years reduced
the risk of PMS (15). The consumption of A, B,
C, and E vitamins and magnesium and calcium
(16) and the consumption of non-hem ferric and
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reduction of salt consumption (15) decreased PMS
signs. Our study and other researches showed no
relationship between serum elements and PMS.
But why the consumption of essential elements did
help PMS sign management? Although the levels of
neurotransmitters and sexual hormones in PMS and
non-PMS cases are similar, the oscillations of these
factors from follicular to luteal phase are gradual
in normal persons and sudden in PMS cases (17).
Therefore, these sudden oscillations could be the
reason for the increase in an instantaneous need
for effective factors including essential elements
and vitamins and a slight decrease of these
factors should lead to unpleasant PMS symptoms.
Studies showed that the serum level of essential
elements and vitamins reduced in PMS cases but
the reduction was insignificant. It is worth noting that
even the minimum normal range of these factors
should be considered in PMS cases and should rise
to a higher degree.
Vitamin D reduction has been proven in many
Iranian societies, both male and female (18), but
a very few documents compare its levels in
PMS and non-PMS times. A number of studies
have shown a reduction of some PMS symptoms
including anxiety, irritability, homesickness, and
crying, following vitamin D consumption in PMS
cases suffering vitamin D deficiency (19, 20). In this
study, the level of vitamin D in both normal and
PMS groups decreased, but the PMS cases had a
significantly lower range of vitamin D (p ≤0.05).
Some researchers have reported vitamin D
reduction during the luteal phase in PMS women
(19). In spite of these reports, the major circulating
form of vitamin D (25 (OH) D) didn’t show any
significant difference between the control and PMS
cases in other researches (21, 22).
Vitamin D is a neurosteroid and its receptors
are located in different parts of the brain,
especially in the hippocampus. This vitamin and
its receptor have been linked to several brain
disorders, including cognitive decline, epilepsy,
affective disorders, and schizophrenia (23). Vitamin
D also has receptors on immune cells and as
immunomodulator can inhibit inflammatory reaction
during the menstrual cycle. Moreover, this vitamin
prevents prostaglandins production by inhibition of
cyclooxygenase 2 and NO synthesis (24, 25). With
regard to the two major factors of body pain that
are pre-inflammatory cytokines and prostaglandins
(25), vitamin D deficiency or defects in its receptors
may cause mental and physical disorders in
PMS cases.
Recently, several genetic mutations have been
known in the vitamin D receptor (VDR). One of
them, among many others, is the Fok1 single
nucleotide polymorphism that has been linked to
gynecological disorders as uterine leiomyoma and
polycystic ovary (26, 27). Hussain et al. according
to a study on 340 female students from the Dubai
Medical University reported that the frequency
of F-containing genotypes between VDR Fok1
genotypes (FF, Ff, and ff) was significantly higher
among the PMS group (56.8%) than the control
group (44.1%). Moreover, the risk of susceptibility
to depressive, PMS, and mood disorders was
markedly increased in ff genotype (28, 29). Due
to the effect of VDR-Fok1 polymorphism on the
mood and daily activity (30) in our research, this
polymorphism has probably also played a role.
However, widespread studies need to verify this
claim.
5. Conclusion
Our results showed that the PMS prevalence
was about 41.5% among a number of students from
the city of Falavarjan. There were no significant
differences in the serum levels of a number of
trace elements in the PMS group compared with the
health group. Although the vitamin D levels in both
the groups were lower than the normal range, in the
PMS group, it was significantly less than the health
group. So in order to reduce the PMS symptoms,
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serum level of vitamin D should be at the highest
level within the normal range.
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